TargetMol

Transcainide

Product Code:
 
TAR-T26287
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26287-1mg1mg£286.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26287-5mg5mg£603.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26287-10mg10mg£828.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26287-25mg25mg£1,187.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26287-50mg50mg£1,581.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26287-100mg100mg£2,127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Transcainide is an antiarrhythmic agent with potential clinical application.
CAS:
88296-62-2
Formula:
C22H35N3O2
Molecular Weight:
373.541
Pathway:
Membrane transporter/Ion channel
Purity:
0.98
SMILES:
CN(C)C1(CCN(CC1)[C@@H]1CCCC[C@H]1O)C(=O)Nc1c(C)cccc1C
Target:
Sodium Channel

References

1. Carmeliet E, Janssen PA, Heykants J, Niemegeers CJ, Remeysen P, Van De Water A, Van Gerven W, Wauquier A, Xhonneux R. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide. Arch Int Pharmacodyn Ther. 1987 Jun;287(2):272-90. PubMed PMID: 3632145. 2. Bennett PB, Stroobandt R, Kesteloot H, Hondeghem LM. Sodium channel block by a potent, new antiarrhythmic agent, transcainide, in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 1987 Jun;9(6):661-7. PubMed PMID: 2442531. 3. Yang X, Yu T, Kesteloot H. Clinical and electrophysiologic studies of R61748 (transcainide): a new class Ic antiarrhythmic drug. Acta Cardiol. 1992;47(1):43-56. PubMed PMID: 1378674. 4. Hill RJ, Thakore E, Taouis M, Duff HJ, Sheldon RS. Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor. Eur J Pharmacol. 1991 Oct 2;203(1):51-8. PubMed PMID: 1665791.